CNBC spoke with 11 current and former Pfizer employees, who asked to remain anonymous, about Pfizer's dizzying climb, rapid decline and turnaround strategy.
from Business News https://ift.tt/0pIi4mF
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
0